Back to Search
Start Over
Central Precocious Puberty in an Infant with Sotos Syndrome and Response to Treatment
- Source :
- JCRPE, Vol 14, Iss 3, Pp 356-360 (2022)
- Publication Year :
- 2022
- Publisher :
- Galenos Yayincilik, 2022.
-
Abstract
- Sotos syndrome (SS) is characterized by overgrowth, distinctive facial appearance, and learning disability. It is caused by heterozygous mutations, including deletions of NSD1 located at chromosome 5q35. While advanced bone age can occur in some cases, precocious puberty (PP) has only been reported in three cases previously. Here, we reported a case of SS diagnosed in the infancy period with central PP. The discovery of potential factors that trigger puberty is one of the central mysteries of pubertal biology. Depot gonadotropinreleasing hormone analogs constitute the first-line therapy in central PP (CPP), which has proven to be both effective and safe. In our cases, leuprolide acetate at maximum dose was not successful in controlling pubertal progression, and cyproterone acetate (CPA) was added to therapy, with successful control of pubertal progression. In some specific syndromes with PP, such as SS, treatment can be challenging. CPA may be an asset for effective treatment.
Details
- Language :
- English
- ISSN :
- 13085727 and 73463752
- Volume :
- 14
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- JCRPE
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7346375232a943988a4c604ee7cf3841
- Document Type :
- article
- Full Text :
- https://doi.org/10.4274/jcrpe.galenos.2021.2020.0273